Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Growth (Status and Outlook) 2025-2031
According to this study, the global HIV Integrase Strand Transfer Inhibitors (INSTI) market size will reach US$ million by 2031.
United States market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key HIV Integrase Strand Transfer Inhibitors (INSTI) players cover Adcock Ingram Limited, Affine Formulations Limited, Aurobindo Pharma, Biocon Limited, Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Forecast” looks at past sales and reviews total world HIV Integrase Strand Transfer Inhibitors (INSTI) sales in 2024, providing a comprehensive analysis by region and market sector of projected HIV Integrase Strand Transfer Inhibitors (INSTI) sales for 2025 through 2031. With HIV Integrase Strand Transfer Inhibitors (INSTI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV Integrase Strand Transfer Inhibitors (INSTI) industry.
This Insight Report provides a comprehensive analysis of the global HIV Integrase Strand Transfer Inhibitors (INSTI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HIV Integrase Strand Transfer Inhibitors (INSTI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HIV Integrase Strand Transfer Inhibitors (INSTI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV Integrase Strand Transfer Inhibitors (INSTI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV Integrase Strand Transfer Inhibitors (INSTI).
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Integrase Strand Transfer Inhibitors (INSTI) market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for HIV Integrase Strand Transfer Inhibitors (INSTI) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key HIV Integrase Strand Transfer Inhibitors (INSTI) players cover Adcock Ingram Limited, Affine Formulations Limited, Aurobindo Pharma, Biocon Limited, Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “HIV Integrase Strand Transfer Inhibitors (INSTI) Industry Forecast” looks at past sales and reviews total world HIV Integrase Strand Transfer Inhibitors (INSTI) sales in 2024, providing a comprehensive analysis by region and market sector of projected HIV Integrase Strand Transfer Inhibitors (INSTI) sales for 2025 through 2031. With HIV Integrase Strand Transfer Inhibitors (INSTI) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HIV Integrase Strand Transfer Inhibitors (INSTI) industry.
This Insight Report provides a comprehensive analysis of the global HIV Integrase Strand Transfer Inhibitors (INSTI) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HIV Integrase Strand Transfer Inhibitors (INSTI) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HIV Integrase Strand Transfer Inhibitors (INSTI) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HIV Integrase Strand Transfer Inhibitors (INSTI) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HIV Integrase Strand Transfer Inhibitors (INSTI).
This report presents a comprehensive overview, market shares, and growth opportunities of HIV Integrase Strand Transfer Inhibitors (INSTI) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Raltegravir
- Elvitegravir Combination Drugs
- Dolutegravir and Its Combination Drug
- Bictegravir Combination Drug
- Cabotegravir
- Others
- Hospital
- Clinic
- Drug Center
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Adcock Ingram Limited
- Affine Formulations Limited
- Aurobindo Pharma
- Biocon Limited
- Bristol-Myers Squibb
- Cipla
- Emcure Pharmaceuticals
- Flamingo Pharmaceuticals Limited
- Gilead Sciences
- Hetero Drugs
- IPCA Laboratories
- Janssen Pharmaceutica (Johnson & Johnson)
- LAURUS Labs
- Medisist Pharma
- Merck
- Mylan
- Ranbaxy Pharmaceuticals
- Shanghai Desano Pharmaceuticals
- ViiV Healthcare (GSK)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2020-2031)
2.1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for HIV Integrase Strand Transfer Inhibitors (INSTI) by Country/Region (2020, 2024 & 2031)
2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Type
2.2.1 Raltegravir
2.2.2 Elvitegravir Combination Drugs
2.2.3 Dolutegravir and Its Combination Drug
2.2.4 Bictegravir Combination Drug
2.2.5 Cabotegravir
2.2.6 Others
2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
2.3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
2.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drug Center
2.4.4 Others
2.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
2.5.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
3 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SIZE BY PLAYER
3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Player
3.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Player (2020-2025)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Player (2020-2025)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) BY REGION
4.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Annual Revenue by Country/Region (2020-2025)
4.3 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
4.4 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
4.5 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
4.6 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
5.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
5.3 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025)
6.2 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
6.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) by Region (2020-2025)
8.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
8.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET FORECAST
10.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.1.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.1.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.1.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.1.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Country (2026-2031)
10.2.1 United States Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2.2 Canada Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2.3 Mexico Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2.4 Brazil Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.3.1 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast
10.3.2 Japan Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.3 Korea Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.4 Southeast Asia Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.5 India Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.6 Australia Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Country (2026-2031)
10.4.1 Germany Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.2 France Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.3 UK Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.4 Italy Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.5 Russia Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.5.1 Egypt Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5.2 South Africa Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5.3 Israel Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5.4 Turkey Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.6 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Type (2026-2031)
10.7 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Application (2026-2031)
10.7.1 GCC Countries Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Adcock Ingram Limited
11.1.1 Adcock Ingram Limited Company Information
11.1.2 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Adcock Ingram Limited Main Business Overview
11.1.5 Adcock Ingram Limited Latest Developments
11.2 Affine Formulations Limited
11.2.1 Affine Formulations Limited Company Information
11.2.2 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Affine Formulations Limited Main Business Overview
11.2.5 Affine Formulations Limited Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Biocon Limited
11.4.1 Biocon Limited Company Information
11.4.2 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Biocon Limited Main Business Overview
11.4.5 Biocon Limited Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Emcure Pharmaceuticals
11.7.1 Emcure Pharmaceuticals Company Information
11.7.2 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Emcure Pharmaceuticals Main Business Overview
11.7.5 Emcure Pharmaceuticals Latest Developments
11.8 Flamingo Pharmaceuticals Limited
11.8.1 Flamingo Pharmaceuticals Limited Company Information
11.8.2 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Flamingo Pharmaceuticals Limited Main Business Overview
11.8.5 Flamingo Pharmaceuticals Limited Latest Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Information
11.9.2 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Gilead Sciences Main Business Overview
11.9.5 Gilead Sciences Latest Developments
11.10 Hetero Drugs
11.10.1 Hetero Drugs Company Information
11.10.2 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Hetero Drugs Main Business Overview
11.10.5 Hetero Drugs Latest Developments
11.11 IPCA Laboratories
11.11.1 IPCA Laboratories Company Information
11.11.2 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 IPCA Laboratories Main Business Overview
11.11.5 IPCA Laboratories Latest Developments
11.12 Janssen Pharmaceutica (Johnson & Johnson)
11.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Information
11.12.2 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Janssen Pharmaceutica (Johnson & Johnson) Main Business Overview
11.12.5 Janssen Pharmaceutica (Johnson & Johnson) Latest Developments
11.13 LAURUS Labs
11.13.1 LAURUS Labs Company Information
11.13.2 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 LAURUS Labs Main Business Overview
11.13.5 LAURUS Labs Latest Developments
11.14 Medisist Pharma
11.14.1 Medisist Pharma Company Information
11.14.2 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Medisist Pharma Main Business Overview
11.14.5 Medisist Pharma Latest Developments
11.15 Merck
11.15.1 Merck Company Information
11.15.2 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Merck Main Business Overview
11.15.5 Merck Latest Developments
11.16 Mylan
11.16.1 Mylan Company Information
11.16.2 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Mylan Main Business Overview
11.16.5 Mylan Latest Developments
11.17 Ranbaxy Pharmaceuticals
11.17.1 Ranbaxy Pharmaceuticals Company Information
11.17.2 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Ranbaxy Pharmaceuticals Main Business Overview
11.17.5 Ranbaxy Pharmaceuticals Latest Developments
11.18 Shanghai Desano Pharmaceuticals
11.18.1 Shanghai Desano Pharmaceuticals Company Information
11.18.2 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Shanghai Desano Pharmaceuticals Main Business Overview
11.18.5 Shanghai Desano Pharmaceuticals Latest Developments
11.19 ViiV Healthcare (GSK)
11.19.1 ViiV Healthcare (GSK) Company Information
11.19.2 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 ViiV Healthcare (GSK) Main Business Overview
11.19.5 ViiV Healthcare (GSK) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size (2020-2031)
2.1.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for HIV Integrase Strand Transfer Inhibitors (INSTI) by Country/Region (2020, 2024 & 2031)
2.2 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Type
2.2.1 Raltegravir
2.2.2 Elvitegravir Combination Drugs
2.2.3 Dolutegravir and Its Combination Drug
2.2.4 Bictegravir Combination Drug
2.2.5 Cabotegravir
2.2.6 Others
2.3 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type
2.3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
2.4 HIV Integrase Strand Transfer Inhibitors (INSTI) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drug Center
2.4.4 Others
2.5 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application
2.5.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
3 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET SIZE BY PLAYER
3.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Player
3.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Player (2020-2025)
3.1.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Player (2020-2025)
3.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) BY REGION
4.1 HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025)
4.2 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Annual Revenue by Country/Region (2020-2025)
4.3 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
4.4 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
4.5 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
4.6 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
5.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
5.3 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025)
6.2 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
6.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025)
7.2 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
7.3 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) by Region (2020-2025)
8.2 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025)
8.3 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HIV INTEGRASE STRAND TRANSFER INHIBITORS (INSTI) MARKET FORECAST
10.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.1.1 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.1.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.1.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.1.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.1.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2 Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Country (2026-2031)
10.2.1 United States Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2.2 Canada Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2.3 Mexico Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.2.4 Brazil Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3 APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.3.1 China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Forecast
10.3.2 Japan Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.3 Korea Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.4 Southeast Asia Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.5 India Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.3.6 Australia Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4 Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Country (2026-2031)
10.4.1 Germany Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.2 France Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.3 UK Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.4 Italy Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.4.5 Russia Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5 Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Region (2026-2031)
10.5.1 Egypt Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5.2 South Africa Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5.3 Israel Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.5.4 Turkey Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
10.6 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Type (2026-2031)
10.7 Global HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast by Application (2026-2031)
10.7.1 GCC Countries Market HIV Integrase Strand Transfer Inhibitors (INSTI) Forecast
11 KEY PLAYERS ANALYSIS
11.1 Adcock Ingram Limited
11.1.1 Adcock Ingram Limited Company Information
11.1.2 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.1.3 Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Adcock Ingram Limited Main Business Overview
11.1.5 Adcock Ingram Limited Latest Developments
11.2 Affine Formulations Limited
11.2.1 Affine Formulations Limited Company Information
11.2.2 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.2.3 Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Affine Formulations Limited Main Business Overview
11.2.5 Affine Formulations Limited Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.3.3 Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Biocon Limited
11.4.1 Biocon Limited Company Information
11.4.2 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.4.3 Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Biocon Limited Main Business Overview
11.4.5 Biocon Limited Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.5.3 Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Cipla
11.6.1 Cipla Company Information
11.6.2 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.6.3 Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Cipla Main Business Overview
11.6.5 Cipla Latest Developments
11.7 Emcure Pharmaceuticals
11.7.1 Emcure Pharmaceuticals Company Information
11.7.2 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.7.3 Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Emcure Pharmaceuticals Main Business Overview
11.7.5 Emcure Pharmaceuticals Latest Developments
11.8 Flamingo Pharmaceuticals Limited
11.8.1 Flamingo Pharmaceuticals Limited Company Information
11.8.2 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.8.3 Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Flamingo Pharmaceuticals Limited Main Business Overview
11.8.5 Flamingo Pharmaceuticals Limited Latest Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Company Information
11.9.2 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.9.3 Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Gilead Sciences Main Business Overview
11.9.5 Gilead Sciences Latest Developments
11.10 Hetero Drugs
11.10.1 Hetero Drugs Company Information
11.10.2 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.10.3 Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Hetero Drugs Main Business Overview
11.10.5 Hetero Drugs Latest Developments
11.11 IPCA Laboratories
11.11.1 IPCA Laboratories Company Information
11.11.2 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.11.3 IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 IPCA Laboratories Main Business Overview
11.11.5 IPCA Laboratories Latest Developments
11.12 Janssen Pharmaceutica (Johnson & Johnson)
11.12.1 Janssen Pharmaceutica (Johnson & Johnson) Company Information
11.12.2 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.12.3 Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Janssen Pharmaceutica (Johnson & Johnson) Main Business Overview
11.12.5 Janssen Pharmaceutica (Johnson & Johnson) Latest Developments
11.13 LAURUS Labs
11.13.1 LAURUS Labs Company Information
11.13.2 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.13.3 LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 LAURUS Labs Main Business Overview
11.13.5 LAURUS Labs Latest Developments
11.14 Medisist Pharma
11.14.1 Medisist Pharma Company Information
11.14.2 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.14.3 Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Medisist Pharma Main Business Overview
11.14.5 Medisist Pharma Latest Developments
11.15 Merck
11.15.1 Merck Company Information
11.15.2 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.15.3 Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Merck Main Business Overview
11.15.5 Merck Latest Developments
11.16 Mylan
11.16.1 Mylan Company Information
11.16.2 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.16.3 Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Mylan Main Business Overview
11.16.5 Mylan Latest Developments
11.17 Ranbaxy Pharmaceuticals
11.17.1 Ranbaxy Pharmaceuticals Company Information
11.17.2 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.17.3 Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Ranbaxy Pharmaceuticals Main Business Overview
11.17.5 Ranbaxy Pharmaceuticals Latest Developments
11.18 Shanghai Desano Pharmaceuticals
11.18.1 Shanghai Desano Pharmaceuticals Company Information
11.18.2 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.18.3 Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Shanghai Desano Pharmaceuticals Main Business Overview
11.18.5 Shanghai Desano Pharmaceuticals Latest Developments
11.19 ViiV Healthcare (GSK)
11.19.1 ViiV Healthcare (GSK) Company Information
11.19.2 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
11.19.3 ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 ViiV Healthcare (GSK) Main Business Overview
11.19.5 ViiV Healthcare (GSK) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. HIV Integrase Strand Transfer Inhibitors (INSTI) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Raltegravir
Table 4. Major Players of Elvitegravir Combination Drugs
Table 5. Major Players of Dolutegravir and Its Combination Drug
Table 6. Major Players of Bictegravir Combination Drug
Table 7. Major Players of Cabotegravir
Table 8. Major Players of Others
Table 9. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Table 12. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Table 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Player (2020-2025) & ($ millions)
Table 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Player (2020-2025)
Table 17. HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Products Offered
Table 18. HIV Integrase Strand Transfer Inhibitors (INSTI) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & ($ millions)
Table 22. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Table 23. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Country (2020-2025)
Table 27. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Table 29. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Table 31. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Table 33. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Country (2020-2025)
Table 37. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table 43. Key Market Challenges & Risks of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table 44. Key Industry Trends of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table 45. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Adcock Ingram Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 50. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 51. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Adcock Ingram Limited Main Business
Table 53. Adcock Ingram Limited Latest Developments
Table 54. Affine Formulations Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 55. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 56. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Affine Formulations Limited Main Business
Table 58. Affine Formulations Limited Latest Developments
Table 59. Aurobindo Pharma Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 60. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 61. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Aurobindo Pharma Main Business
Table 63. Aurobindo Pharma Latest Developments
Table 64. Biocon Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 65. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 66. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Biocon Limited Main Business
Table 68. Biocon Limited Latest Developments
Table 69. Bristol-Myers Squibb Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 70. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 71. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Bristol-Myers Squibb Main Business
Table 73. Bristol-Myers Squibb Latest Developments
Table 74. Cipla Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 75. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 76. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Cipla Main Business
Table 78. Cipla Latest Developments
Table 79. Emcure Pharmaceuticals Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 80. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 81. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Emcure Pharmaceuticals Main Business
Table 83. Emcure Pharmaceuticals Latest Developments
Table 84. Flamingo Pharmaceuticals Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 85. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 86. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Flamingo Pharmaceuticals Limited Main Business
Table 88. Flamingo Pharmaceuticals Limited Latest Developments
Table 89. Gilead Sciences Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 90. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 91. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Gilead Sciences Main Business
Table 93. Gilead Sciences Latest Developments
Table 94. Hetero Drugs Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 95. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 96. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Hetero Drugs Main Business
Table 98. Hetero Drugs Latest Developments
Table 99. IPCA Laboratories Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 100. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 101. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. IPCA Laboratories Main Business
Table 103. IPCA Laboratories Latest Developments
Table 104. Janssen Pharmaceutica (Johnson & Johnson) Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 105. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 106. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Janssen Pharmaceutica (Johnson & Johnson) Main Business
Table 108. Janssen Pharmaceutica (Johnson & Johnson) Latest Developments
Table 109. LAURUS Labs Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 110. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 111. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. LAURUS Labs Main Business
Table 113. LAURUS Labs Latest Developments
Table 114. Medisist Pharma Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 115. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 116. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Medisist Pharma Main Business
Table 118. Medisist Pharma Latest Developments
Table 119. Merck Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 120. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 121. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Merck Main Business
Table 123. Merck Latest Developments
Table 124. Mylan Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 125. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 126. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 127. Mylan Main Business
Table 128. Mylan Latest Developments
Table 129. Ranbaxy Pharmaceuticals Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 130. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 131. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 132. Ranbaxy Pharmaceuticals Main Business
Table 133. Ranbaxy Pharmaceuticals Latest Developments
Table 134. Shanghai Desano Pharmaceuticals Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 135. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 136. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 137. Shanghai Desano Pharmaceuticals Main Business
Table 138. Shanghai Desano Pharmaceuticals Latest Developments
Table 139. ViiV Healthcare (GSK) Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 140. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 141. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 142. ViiV Healthcare (GSK) Main Business
Table 143. ViiV Healthcare (GSK) Latest Developments
Table 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. HIV Integrase Strand Transfer Inhibitors (INSTI) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Raltegravir
Table 4. Major Players of Elvitegravir Combination Drugs
Table 5. Major Players of Dolutegravir and Its Combination Drug
Table 6. Major Players of Bictegravir Combination Drug
Table 7. Major Players of Cabotegravir
Table 8. Major Players of Others
Table 9. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Table 12. HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 14. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Table 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Player (2020-2025) & ($ millions)
Table 16. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Player (2020-2025)
Table 17. HIV Integrase Strand Transfer Inhibitors (INSTI) Key Players Head office and Products Offered
Table 18. HIV Integrase Strand Transfer Inhibitors (INSTI) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & ($ millions)
Table 22. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Table 23. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue by Country/Region (2020-2025) & ($ millions)
Table 24. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Country/Region (2020-2025)
Table 25. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & ($ millions)
Table 26. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Country (2020-2025)
Table 27. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 28. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Table 29. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 30. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Table 31. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & ($ millions)
Table 32. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Table 33. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 34. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 35. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Country (2020-2025) & ($ millions)
Table 36. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Country (2020-2025)
Table 37. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 38. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 39. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Region (2020-2025) & ($ millions)
Table 40. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Type (2020-2025) & ($ millions)
Table 41. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size by Application (2020-2025) & ($ millions)
Table 42. Key Market Drivers & Growth Opportunities of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table 43. Key Market Challenges & Risks of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table 44. Key Industry Trends of HIV Integrase Strand Transfer Inhibitors (INSTI)
Table 45. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 46. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share Forecast by Region (2026-2031)
Table 47. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 48. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 49. Adcock Ingram Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 50. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 51. Adcock Ingram Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 52. Adcock Ingram Limited Main Business
Table 53. Adcock Ingram Limited Latest Developments
Table 54. Affine Formulations Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 55. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 56. Affine Formulations Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 57. Affine Formulations Limited Main Business
Table 58. Affine Formulations Limited Latest Developments
Table 59. Aurobindo Pharma Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 60. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 61. Aurobindo Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 62. Aurobindo Pharma Main Business
Table 63. Aurobindo Pharma Latest Developments
Table 64. Biocon Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 65. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 66. Biocon Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 67. Biocon Limited Main Business
Table 68. Biocon Limited Latest Developments
Table 69. Bristol-Myers Squibb Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 70. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 71. Bristol-Myers Squibb HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 72. Bristol-Myers Squibb Main Business
Table 73. Bristol-Myers Squibb Latest Developments
Table 74. Cipla Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 75. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 76. Cipla HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 77. Cipla Main Business
Table 78. Cipla Latest Developments
Table 79. Emcure Pharmaceuticals Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 80. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 81. Emcure Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 82. Emcure Pharmaceuticals Main Business
Table 83. Emcure Pharmaceuticals Latest Developments
Table 84. Flamingo Pharmaceuticals Limited Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 85. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 86. Flamingo Pharmaceuticals Limited HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 87. Flamingo Pharmaceuticals Limited Main Business
Table 88. Flamingo Pharmaceuticals Limited Latest Developments
Table 89. Gilead Sciences Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 90. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 91. Gilead Sciences HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 92. Gilead Sciences Main Business
Table 93. Gilead Sciences Latest Developments
Table 94. Hetero Drugs Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 95. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 96. Hetero Drugs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 97. Hetero Drugs Main Business
Table 98. Hetero Drugs Latest Developments
Table 99. IPCA Laboratories Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 100. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 101. IPCA Laboratories HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 102. IPCA Laboratories Main Business
Table 103. IPCA Laboratories Latest Developments
Table 104. Janssen Pharmaceutica (Johnson & Johnson) Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 105. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 106. Janssen Pharmaceutica (Johnson & Johnson) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 107. Janssen Pharmaceutica (Johnson & Johnson) Main Business
Table 108. Janssen Pharmaceutica (Johnson & Johnson) Latest Developments
Table 109. LAURUS Labs Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 110. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 111. LAURUS Labs HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 112. LAURUS Labs Main Business
Table 113. LAURUS Labs Latest Developments
Table 114. Medisist Pharma Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 115. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 116. Medisist Pharma HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 117. Medisist Pharma Main Business
Table 118. Medisist Pharma Latest Developments
Table 119. Merck Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 120. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 121. Merck HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 122. Merck Main Business
Table 123. Merck Latest Developments
Table 124. Mylan Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 125. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 126. Mylan HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 127. Mylan Main Business
Table 128. Mylan Latest Developments
Table 129. Ranbaxy Pharmaceuticals Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 130. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 131. Ranbaxy Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 132. Ranbaxy Pharmaceuticals Main Business
Table 133. Ranbaxy Pharmaceuticals Latest Developments
Table 134. Shanghai Desano Pharmaceuticals Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 135. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 136. Shanghai Desano Pharmaceuticals HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 137. Shanghai Desano Pharmaceuticals Main Business
Table 138. Shanghai Desano Pharmaceuticals Latest Developments
Table 139. ViiV Healthcare (GSK) Details, Company Type, HIV Integrase Strand Transfer Inhibitors (INSTI) Area Served and Its Competitors
Table 140. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Product Offered
Table 141. ViiV Healthcare (GSK) HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 142. ViiV Healthcare (GSK) Main Business
Table 143. ViiV Healthcare (GSK) Latest Developments
LIST OF FIGURES
Figure 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Country/Region (2024)
Figure 8. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type in 2024
Figure 10. HIV Integrase Strand Transfer Inhibitors (INSTI) in Hospital
Figure 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Hospital (2020-2025) & ($ millions)
Figure 12. HIV Integrase Strand Transfer Inhibitors (INSTI) in Clinic
Figure 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Clinic (2020-2025) & ($ millions)
Figure 14. HIV Integrase Strand Transfer Inhibitors (INSTI) in Drug Center
Figure 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Drug Center (2020-2025) & ($ millions)
Figure 16. HIV Integrase Strand Transfer Inhibitors (INSTI) in Others
Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Others (2020-2025) & ($ millions)
Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application in 2024
Figure 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Player in 2024
Figure 20. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Figure 21. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 22. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 23. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 25. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Value Market Share by Country in 2024
Figure 26. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region in 2024
Figure 31. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Figure 32. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Figure 33. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 37. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Country in 2024
Figure 40. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Figure 41. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Figure 42. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 43. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 44. UK HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Figure 50. Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 56. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 57. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 59. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 60. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 61. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 62. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 63. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 64. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 65. Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 67. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 68. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 69. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 70. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 71. UK HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 72. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 73. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 74. Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 75. South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 76. Israel HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 77. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 78. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 1. HIV Integrase Strand Transfer Inhibitors (INSTI) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Country/Region (2024)
Figure 8. HIV Integrase Strand Transfer Inhibitors (INSTI) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type in 2024
Figure 10. HIV Integrase Strand Transfer Inhibitors (INSTI) in Hospital
Figure 11. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Hospital (2020-2025) & ($ millions)
Figure 12. HIV Integrase Strand Transfer Inhibitors (INSTI) in Clinic
Figure 13. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Clinic (2020-2025) & ($ millions)
Figure 14. HIV Integrase Strand Transfer Inhibitors (INSTI) in Drug Center
Figure 15. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Drug Center (2020-2025) & ($ millions)
Figure 16. HIV Integrase Strand Transfer Inhibitors (INSTI) in Others
Figure 17. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market: Others (2020-2025) & ($ millions)
Figure 18. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application in 2024
Figure 19. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Revenue Market Share by Player in 2024
Figure 20. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Figure 21. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 22. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 23. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2020-2025 ($ millions)
Figure 25. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Value Market Share by Country in 2024
Figure 26. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region in 2024
Figure 31. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Figure 32. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Figure 33. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 37. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Country in 2024
Figure 40. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Figure 41. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Figure 42. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 43. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 44. UK HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share by Application (2020-2025)
Figure 50. Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 56. APAC HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 57. Europe HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 59. United States HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 60. Canada HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 61. Mexico HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 62. Brazil HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 63. China HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 64. Japan HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 65. Korea HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 67. India HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 68. Australia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 69. Germany HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 70. France HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 71. UK HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 72. Italy HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 73. Russia HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 74. Egypt HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 75. South Africa HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 76. Israel HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 77. Turkey HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
Figure 78. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries HIV Integrase Strand Transfer Inhibitors (INSTI) Market Size 2026-2031 ($ millions)
More Publications
Global Dye Transfer Inhibitor Market Growth 2025-2031
US$ 3,660.00
March 2025
78 pages
Global Closed Drug Transfer Systems Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
January 2025
78 pages
Global Cox-2 Inhibitors Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
89 pages
Global Selective Cox-2 Inhibitors Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
167 pages
